Brianne, Alzheimers, Probiotics, and CBD
Dr. David Hepburn - In a remarkable paper, neurologist Ethan Russo connects receptors, epidemiology, the microbiome, neuroinflammation, and cannabis to explain possible therapeutic targets in treatments of troubling neurodegenerative conditions.
Cannabis Research in Tourette Syndrome
Dr. David Hepburn - An Israeli study showed that of the patients without syndrome who tolerated cannabis treatment, many experienced a reduction in tic severity, better sleep and improved moo
Dr. David Hepburn - Men appear to have 41% more CB1 receptors in the brain. Unfortunately for men of the male species, this is inversely related to working memory. (No memory of working). https://medicalcannabisuses.bl....ogspot.com/2019/01/w
THC: Brain Benefits or Bust Depends on Age
Dr. David Hepburn - Findings presented at Neuroscience 2018 show that cannabis can either harness or hijack our endocannabinoid system. Takentoosoonit can hijack and interfere with the brain intended ECS development.
Dr. David Frederick Hepburn, MD is Canada’s foremost medical cannabis educator of physicians and the scientific and lay communities. He is a member of the Society of Cannabis Clinicians (SCC), International Association for Cannabinoid Medicines (IACM), the Canadian Consortium for the Investigation of Cannabinoids (CCIC) and Physicians for Medical Cannabis (PMC).